Thirty three marine species are poised to invade Australian waters, and could seriously alter the balance of marine life or even pose a risk to human health if they reach our coasts.

In an international response to the threat, researchers from CSIRO and the Smithsonian Environmental Research Center, Maryland, have joined forces to develop a rapid response strategy to combat invasion.

CSIRO risk assessment scientists have identified the most damaging marine species from around the

Australian windpower technology is reaching out to a global market, as science, technology and industry come together in a new wind energy consulting company based in Canberra.

Former CSIRO scientists, Dr Keith Ayotte and Dr Nathan Steggel developed what is seen to be world’s best available wind resource technology, WindScape and Raptor NL.

Windscape is believed to be the leading wind mapping tool and enables power prospectors to find the windiest spots down to property boundaries

Aging has long been recognized as the worst risk factor for chronic ailments like atherosclerosis, which clogs arteries and leads to heart attacks and stroke. Yet, the mechanism by which aging promotes the clogging of arteries has remained an enigma.

Scientists at Duke University Medical Center have discovered that a major problem with aging is an unexpected failure of the bone marrow to produce progenitor cells that are needed to repair and rejuvenate arteries exposed to such environmental

Remain a hematopoetic stem cell or become a specialized blood cell?

Hematopoietic stem cells, the mother of all blood cells, face a fundamental dilemma in their lives.

Each must either remain a hematopoietic stem cell (HSC) by renewing itself or it must transform into one of eight specialized types of blood cells, such as a red blood cell, a white blood cell or a platelet.

Until recently, scientists didn’t know how the essential cells, which exist in limited a

Scientists have used a technique called RNA interference to impair cancer cells’ ability to produce a key enzyme called telomerase. The enzyme, present in most major types of cancer cells, gives cells the lethal ability to divide rampantly without dying. The laboratory experiments create an opportunity for researchers who are focusing on telomerase in a bid to develop a drug like none ever developed – one capable of killing 85 percent of cancers

The research, led by Peter T. Rowley, M.

UT Southwestern Medical Center at Dallas researchers have taken the first step in defining the sites in human genes most prone to mutation, which eventually could lead to discovery of the genetic bases of many human diseases.

Their work will appear in an upcoming issue of the journal Gene and is currently available online.

Dr. Harold “Skip” Garner, professor of biochemistry and internal medicine, and his colleagues made their discovery while mining databases of coding single nucle